Fortune Rise Acquisition Corp. (FRLA) Sponsor Sells Interest to Water On Demand
by Marlena Haddad on 2022-12-29 at 5:31pm

Fortune Rise Acquisition Corp. (NASDAQ: FRLA) announced this afternoon that it has entered into a membership interest purchase and transfer agreement resulting in a change in leadership.

On December 22, FRLA’s sponsor, Fortune Rise Sponsor LLC, entered into a purchase agreement with water fintech startup Water On Demand, Inc. (WODI), Ka Wai Cheung, Koon Lin Chan, and Koon Keung Chan pursuant to which WODI purchased 100 membership interests in the sponsor, constituting 100% of the membership interests in the sponsor. The sponsor holds 2,343,750 shares out of 2,443,750 shares of the issued and outstanding shares of Class B Common Stock of Fortune Rise. The purchase price for the membership interests was $403,516.61.

As a result of the purchased interests, the officers and members of the Board of Directors of Fortune Rise tendered their resignations and WODI, as the holder of a majority of the Class B Common Stock, appointed Payam Eshraghian as the sole director and Chairman of the Board of Directors. He will also serve as a Member of the Audit Committee and a Member of the Compensation Committee.

Mr. Eshraghian, also known as Mr. Ian, is the Founder and President of Nerve, LLC, an insurtech and fintech software firm headquartered in California. He is also a strategic advisor for Agtools Inc., an AgriTech SaaS company mitigating risks across the global food supply chain.

Mr. Ian has appointed J. Richard Iler to serve as Fortune Rise’s Principal Executive Officer, CFO, Secretary, and Treasurer. Mr. Iler has spent his professional career in the capital markets working in various positions such as corporate finance, CFO of both public and private companies, and an institutional corporate bond salesman.

Additionally, Mr. Ian has appointed Ronald J. Pollack and Ryan Spick to serve as the company’s directors to fill vacancies left by outgoing directors.

Mr. Pollack is an experienced financial professional, angel investor and board member. He currently serves on the Board of Directors of Ronati and Venocare and the Advisory Board of CISO Global (NASDAQ: CISO). Mr. Pollack previously served on the Board of Directors of TiE Tampa and co-chair of its Florida angel network. Mr. Pollack was the Founder and Managing Partner of Bulldog Capital Management, a $1+ billion family of investment funds with a special focus on technology. He will also serve as Fortune Rise’s Chair of Audit Committee and a Member of the Compensation Committee.

Mr. Spick works with business owners to scale their companies through analysis and targeted improvements. His expertise ranges from determining target audience, market research, branding, developing budgets, estimates, scopes of work to client relations, as well as implementing back-office functions and coordinating with trades.  Mr. Spick will also serve as Fortune’s Chair of the Compensation Committee and a Member of the Audit Committee.

Fortune Rise announced its $85 million IPO in November 2021. The SPAC inked a $294 million deal with crypto mining business VCV Digital Technology in May 2022, but the business combination was terminated just two months after the announcement.

 

Recent Posts
by Nicholas Alan Clayton on 2024-12-24 at 2:07pm

Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...

by Nicholas Alan Clayton on 2024-12-24 at 8:13am

At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...

by Nicholas Alan Clayton on 2024-12-23 at 3:40pm

Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...

by Kristi Marvin on 2024-12-23 at 10:52am

Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...

by Nicholas Alan Clayton on 2024-12-23 at 8:18am

At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved